The article discusses the stigmatization of antidepressants in Germany, focusing on personal experience with escitalopram for chronic headaches caused by psychosomatic factors. The author describes how despite medical evidence supporting their efficacy, antidepressants are often dismissed or discouraged by healthcare professionals, including pharmacists and therapists. They recount their struggle over 14 years to find relief through medication, which significantly reduced their symptoms. The piece highlights the ongoing taboo around antidepressive treatment and calls for an end to this stigma, emphasizing that these medications are not a substitute for therapy but can be part of a comprehensive approach to mental health.
Bias read (Progressive): The article frames the issue of antidepressant stigma as a societal and professional failure, particularly within the healthcare system. It criticizes the dismissive attitudes of some practitioners toward medication as a valid treatment option, implying a broader cultural resistance to acknowledging
Why factuality (85): The article presents personal experience with antidepressants, specifically escitalopram, and describes its positive impact on the author's quality of life. It references general statistics about mental health prevalence and antidepressant usage in Germany, aligning with broader public health data.
Why objectivity (70): The tone is emotionally charged, reflecting the author's personal struggle and relief from medication. While the article does not overtly promote or criticize antidepressants, it frames them as a necessary treatment rather than a 'quick fix,' which may subtly favor their use. The narrative is subjec





